Cerus starts Phase I study of blood system

11/25/2008 | RTT News

Cerus Corp. has commenced a Phase I clinical trial of its INTERCEPT Blood System for red blood cells to evaluate the post-transfusion recovery and lifespan of patients who received transfusions with INTERCEPT-treated red blood cells compared with patients who received transfusions with untreated red blood cells. The trial is expected to conclude in the second quarter of 2009.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA